Business Description
Fredun Pharmaceuticals Ltd
ISIN : INE194R01017
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.87 | |||||
Debt-to-EBITDA | 2.6 | |||||
Interest Coverage | 2.67 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.3 | |||||
Beneish M-Score | -1.41 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 30.8 | |||||
3-Year EBITDA Growth Rate | 51.3 | |||||
3-Year EPS without NRI Growth Rate | 64.7 | |||||
3-Year FCF Growth Rate | -77.9 | |||||
3-Year Book Growth Rate | 33.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 24.84 | |||||
9-Day RSI | 36.43 | |||||
14-Day RSI | 40.77 | |||||
6-1 Month Momentum % | 0.28 | |||||
12-1 Month Momentum % | -8.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 204.8 | |||||
Days Sales Outstanding | 48.91 | |||||
Days Payable | 85.49 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.09 | |||||
Dividend Payout Ratio | 0.02 | |||||
3-Year Dividend Growth Rate | 2 | |||||
Forward Dividend Yield % | 0.09 | |||||
5-Year Yield-on-Cost % | 0.1 | |||||
3-Year Average Share Buyback Ratio | -5.6 | |||||
Shareholder Yield % | 0.25 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 20.62 | |||||
Operating Margin % | 10.18 | |||||
Net Margin % | 4.78 | |||||
FCF Margin % | -2.23 | |||||
ROE % | 15.81 | |||||
ROA % | 6.17 | |||||
ROIC % | 13.54 | |||||
ROC (Joel Greenblatt) % | 18.77 | |||||
ROCE % | 28.22 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 20.5 | |||||
PE Ratio without NRI | 20.49 | |||||
Shiller PE Ratio | 56.34 | |||||
PEG Ratio | 0.66 | |||||
PS Ratio | 0.99 | |||||
PB Ratio | 2.94 | |||||
Price-to-Tangible-Book | 2.93 | |||||
EV-to-EBIT | 12.52 | |||||
EV-to-EBITDA | 11.32 | |||||
EV-to-Revenue | 1.27 | |||||
EV-to-FCF | -57.81 | |||||
Price-to-DCF (Earnings Based) | 0.78 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.81 | |||||
Price-to-Graham-Number | 1.71 | |||||
Price-to-Net-Current-Asset-Value | 4.99 | |||||
Earnings Yield (Greenblatt) % | 7.99 | |||||
FCF Yield % | -2.25 | |||||
Forward Rate of Return (Yacktman) % | 16.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Fredun Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 3,628.857 | ||
EPS (TTM) (₹) | 37.03 | ||
Beta | 2.46 | ||
Volatility % | 44.01 | ||
14-Day RSI | 40.77 | ||
14-Day ATR (₹) | 29.830966 | ||
20-Day SMA (₹) | 776.02 | ||
12-1 Month Momentum % | -8.99 | ||
52-Week Range (₹) | 650 - 1054 | ||
Shares Outstanding (Mil) | 4.72 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fredun Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fredun Pharmaceuticals Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Fredun Pharmaceuticals Ltd Frequently Asked Questions
What is Fredun Pharmaceuticals Ltd(BOM:539730)'s stock price today?
When is next earnings date of Fredun Pharmaceuticals Ltd(BOM:539730)?
Does Fredun Pharmaceuticals Ltd(BOM:539730) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |